For the Inventor, By the Inventor

Enter inventor name

Madison, WI, United States of America

James A Thomson

USPTO Granted Patents = 78 (Patent Applications = 29)

CIPO Patents = 21 (Patent Applications = 7)

EPO Patents = 22 (Patent Applications = 28)

Average Co-Inventor Count = 2.3

ph-index = 18

Forward Citations = 2,255(Granted Patents)

Forward Citations (Not Self Cited) = 2,164(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Berkeley, CA (US) (1976)
San Diego, CA (US) (2009 - 2022)
Madison, WI (US) (1998 - 2024)

Company Filing History:

58 out of 4,125

Wisconsin Alumni Research Foundation

Wicell Research Institute, Inc.

Cellular Dynamics International, Inc.

Amgen Fremont Inc.

6. 3 out of 4,455

Pfizer Corporation

8. 4 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1976-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Human Pluripotent Stem Cells

Microglia Derivation

Endothelial Cell Generation

Hepatocyte Culture

Somatic Cell Reprogramming

Chimeric Pegylated ADI

Erythroid Cell Production

Dendritic Cell Formation

Stem Cell Maintenance

Genetic Variation Identification

Monoclonal Antibodies

Defined Surfaces for Stem Cells

78 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12497593 - Generation of hematopoietic progenitor cells from human pluripotent stem cells (2025-12-16),

2. 12454676 - Derivation of human microglia from pluripotent stem cells (2025-10-28),

3. 12410404 - Human pluripotent stem cell-based screening for smooth muscle cell differentiation and disease (2025-09-09),

4. 12370242 - Formulations of pegylated arginine deiminase (2025-07-29),

5. 12344645 - Protein conjugates (2025-07-01),

6. 11898162 - Reprogramming somatic cells into pluripotent cells using a vector encoding Oct4 and Sox2 (2024-02-13),

7. 11674123 - Generating arterial endothelial cell populations (2023-06-13),

8. 11566229 - Expansion and maintenance of adult primary human hepatocytes in culture (2023-01-31),

9. 11395866 - Generating arterial endothelial cell-seeded vascular grafts (2022-07-26),

10. 11235037 - Arginine deiminase with reduced cross-reactivity toward ADI - PEG 20 antibodies for cancer treatment (2022-02-01),

11. 11220672 - Human pluripotent stem cell-based system for generating endothelial cells (2022-01-11),

12. 11124765 - Derivation of human microglia from pluripotent stem cells (2021-09-21),

13. 11116799 - Generation of uniform hepatocytes from human embryonic stem cells by inhibiting TGF-beta and methods of maintaining hepatic cultures (2021-09-14),

14. 11060066 - Human pluripotent stem cell-based models for predictive developmental neural toxicity (2021-07-13),

15. 10760057 - Human pluripotent stem cell-based screening for smooth muscle cell differentiation and disease (2020-09-01),

Title: James A Thomson - Pioneering Innovator in Stem Cell Research

Introduction:

James A Thomson is a visionary inventor in the field of stem cell research, hailing from Madison, WI (US). With an impressive portfolio of 67 patents to his name, Thomson has made significant contributions to the scientific community.

Latest Patents:

1. Reprogramming somatic cells into pluripotent cells using a vector encoding Oct4 and Sox2: Thomson's innovative method focuses on reprogramming somatic cells to pluripotency by administering potency-determining factors. This breakthrough opens up new possibilities in regenerative medicine.

2. Generating arterial endothelial cell populations: Thomson's method for generating human arterial endothelial cells under specific conditions showcases his dedication to advancing research in the field. This invention holds promise for treating peripheral arterial disease and screening potential therapeutic agents.

Career Highlights:

Thomson's groundbreaking work has been showcased through his tenure at renowned establishments such as the Wisconsin Alumni Research Foundation and WiCell Research Institute, Inc. His relentless pursuit of excellence has established him as a trailblazer in the realm of stem cell technology.

Collaborations:

Throughout his illustrious career, Thomson has collaborated with esteemed professionals, including Igor I Slukvin and Maksym A Vodyanyk. These partnerships have led to innovative discoveries and further advancements in the field of stem cell research.

Conclusion:

James A Thomson's dedication to pushing the boundaries of scientific exploration and his commitment to revolutionizing stem cell research make him a pioneering figure in the realm of innovation. His patents and collaborations stand as a testament to his unwavering contribution to the field, shaping the future of regenerative medicine and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…